Copyright
©The Author(s) 2023.
World J Stem Cells. Oct 26, 2023; 15(10): 960-978
Published online Oct 26, 2023. doi: 10.4252/wjsc.v15.i10.960
Published online Oct 26, 2023. doi: 10.4252/wjsc.v15.i10.960
Publication year | Cell source | Induction program | Pretransplantation procedure | Material(s) | Dose/concentration | Disease model | Experiment duration | Treatment effect | Ref. |
2022 | Human | DMEM + 10% (FBS + P/S) | 3D culture | Fibrinogen, calcium chloride, and thrombin-like protein | 3 × 105 cells | Avulsion of spinal motor roots in rats | 12 wk | The transcription of TNF-α, IL-1β, IL-6, and IL-17 and the expression of anti-inflammatory cytokines (TGF-β, IL-4, IL-10, and IL-13) were increased; the animals in the reimplantation + 2D group showed the best functional recovery | [82] |
2021 | Human | α-MEM + 20% (FBS + P/S) | Collected and resuspended in GelMA-bFGF | 10% GFD in a CSM tube | 1 × 106 cells/mL | 15 mm defect of the sciatic nerve in rats | 12 wk | Cell based therapy repaired large gap defects in peripheral nerves; the differentiation of DPSCs into nerve cells and Schwann-like nerve cells and the formation of myelinated nerve fibers were observed | [98] |
2021 | Human | DMEM + 10% (FBS + P/S + NEAA) | NLCs differentiated from DPSCs | - | 1 × 105 NLCs | 10 mm sciatic nerve defect in athymic nude rats | 12 wk | Two weeks after transplantation, approximately 75% of the transplanted cells differentiated into platelet-derived growth factor receptor alpha + OPCs expressing p75NTRd; transplantation promoted axon growth and improved nerve function | [145] |
2021 | Human | α-MEM + 15% FBS | Exosome collection | - | 200 μg/100 μL | Mouse model of spinal cord injury | 4 wk | Inhibited the ROS-MAPK-NFκB P65 signaling pathway to reduce M1 macrophage polarization, suppress the inflammatory response, and alleviate neurological damage | [121] |
2020 | Human | DMEM + 20% (FBS + P/S) | Preparation of scaffold-free cell sheets by coculture with FGF2 | - | 2 × 106 cells/cell sheet | Rat model of facial nerve crush injury | 3 wk | Cell sheets promoted axonal regeneration and functional recovery through continuous delivery of neurotrophic factors such as BDNF and GDNF | [116] |
2020 | Human | α-MEM + 10% (FBS + P/S + NEAA) | Induction of DPSCs differentiation into N-DPSCs; induction of DPSCs differentiation into N-DPSCs | - | - | Rat model of sciatic nerve crush injury | 1 mo | Both DPSCs and N-DPSCs promoted peripheral nerve repair through the expression of neurotrophic factors such as NGF, BDNF, and GDNF; the nerve repair effect of N-DPSCs was longer lasting | [146] |
2019 | Human (children) | DMEM + 15% (FBS+P/S) | - | - | 5 × 105 cells in 4 μL DMEM | Unilateral facial nerve crush injury in rats | 6 wk | Immature DPSCs promoted nerve regeneration and the formation of new myelin; the expression of nerve growth factor and anti-inflammatory cytokines (IL-6 and IL-10) increased significantly 7 d after treatment, and there was a decrease in the levels of soluble proinflammatory factors such as IL-2, IL-4, TNF-α, and IFN-γ | [87] |
2019 | Human | - | Induction of DPSCs differentiation into nerve cells | A PDO-based cell carrier | 7.5 × 105 cells | 6 mm defect of the sciatic nerve in rats | 12 wk | Multiperforated PDO tubes were effective biomaterial carriers; delivery of DPSCs impacted the inflammatory environment and promoted nerve regeneration and functional recovery | [89] |
2018 | Human | - | Isolation of STRO-1+/c-Kit+/CD34+ cells | Collagen scaffolds | 5 × 105 cells/animal | 6 mm defect of the sciatic nerve in rats | 4 wk | Nerve fiber regeneration and myelination and many myelinated axons were observed; DPSCs grafted into the sciatic nerve defect expressed the typical Schwann cell marker S100B and were positive for human NeuN | [12] |
2018 | Human | ADMEM + 10% FBS | Differentiated into neuronal cells (DF-DPSCs) | A conduit made from a Lyoplant membrane | - | 7-8 mm defect of the sciatic nerve in rats | 12 wk | DPSCs relieved neuropathic pain and inhibited inflammation in rats earlier than DF-DPSCs; at 12 wk after the operation, the expression of pAMPK/SIRT1 in DF-DPSCs and DPSCs increased, the expression of proinflammatory cytokines decreased, and the expression of NFκB decreased | [81] |
2018 | Human | ADMEM + 10% (FBS + P/S) | Differentiation into cholinergic neurons by adding D609 | Biodegradable tubule and fibrin glue | 1 × 106 DF-chNs | 5 mm defect of the sciatic nerve in rats | 8 wk | Transplanted DF-chNs promoted motor nerve regeneration and axon growth and expressed nerve growth factor receptor (p75NGFR) | [61] |
2018 | Human | - | - | An absorbable hemostat filled with human DPCs containing 1% atelocollagen, fibronectin, and laminin | 3 × 105 cells | Crush injury of the sciatic nerve in rats | 2 wk | DPCs stimulated Schwann cell differentiation and promoted peripheral nerve regeneration | [114] |
2017 | Human | Standard: α-MEM + 10% (FBS + NEAA + P/S). Differentiation: Standard + forskolin + bFGF + PDGF-AA + HRG1-β | Differentiation into Schwann-like cells (d-hDPSCs) | NeuraWrap™ conduits | - | 15 mm defect of the sciatic nerve in rats | 8 wk | Growth of axons, myelinated nerve fibers, and blood vessels; DPSCs still exerted strong angiogenic effects after differentiating into Schwann-like cells | [102] |
2017 | Human | α-MEM + 15% (FBS + AA + P/S + NEAA) | - | Fibrin conduits | 2 × 106/20 μL | 10 mm defect of the sciatic nerve in rats | 2 wk | Promoted nerve and axon regeneration; the transplanted cells expressed BDNF near the cell body, and the expression level of caspase-3 decreased | [45] |
2017 | Human | ADMEM + 10% FBS | Induction of DPSCs differentiation into nerve cells | Fibrin glue scaffold and collagen tubulation | 1 × 106 cells | 5 mm defect of the sciatic nerve in rats | 12 wk | Both hDPSCs and DF-hDPSCs promoted nerve regeneration and functional recovery; they could directly differentiate into nerve cells or facilitate nerve cell differentiation | [99] |
2015 | Human | α-MEM + 10% (FBS + P/S/AmB) | Transfection with Olig2 gene via a tetracycline (Tet) inducible system | - | 2 × 105 cells | Mouse model of local sciatic nerve demyelination | 6 wk | Recovery of sciatic nerve function; DPSCs differentiated into oligodendrocyte progenitors, and specific markers of oligodendrocyte progenitors and oligodendrocytes were expressed | [108] |
2015 | Human | DMEM + 10% FBS | G-CSF-induced stem cell mobilization (mobilized DPSCs and MDPSCs) | Collagen conduits | 3.0 × 105 MDPSCs | 5 mm defect of the sciatic nerve in rats | 5 wk | MDPSCs secreted neurogenic/angiogenic factors and promoted peripheral nerve regeneration | [112] |
2015 | Human | Culture dishes containing essential medium (alpha modification) + 10% (FBS + P/S + amphotericin B) | Induction of DPSCs differentiation into OPCs by transfection with a plasmid containing the human Olig2 gene | 2 × 105 cells | Sciatic nerve demyelination in mice | 6 wk | DPSCs differentiated into OPCs, and transplantation promoted myelin sheath formation and peripheral nerve function recovery | [107] | |
2015 | Human | DMEM + b-ME; DMEM + 10% (FBS + RA); DMEM + 10% (FBS + FSK + b-FGF + PDGF + HRG) | Differentiation of hDPSCs into Schwann-like cells | Cells combined with a pulsed electromagnetic field (PEMF) | 1 × 106 cells/10 mL/rat | Crush injury of the peripheral nerve in rats | 3 wk | Schwann-like cells derived from DPSCs exhibited the characteristics of glial cells, expressing CD104, S100, GFAP, laminin, and p75NTR; application of a PEMF promoted peripheral nerve regeneration after cell transplantation | [147] |
2012 | Human | DMEM + 10% FBS | - | - | 1 × 106 cells | Rat spinal cord transection model | 8 wk | DPSCs promoted axonal growth, differentiated into oligodendrocytes to treat spinal cord injury, and protected the nerve by inhibiting apoptosis and paracrine signaling | [105] |
2018 | Human | α-MEM + 10% (FBS + NEAA + P/S) | Application of fresh medium containing vitamin C cells reached approximately 80% confluence | - | - | Patients diagnosed with a traumatized permanent incisor | 12 mo | HDPSCs transplantation promoted the regeneration of pulp tissue including neuronal tissue, and the neuron marker NeuN was expressed | [75] |
Human | PBS + P/S | Collection of hDPSCs aggregates | The root canals of human teeth | - | Immunocompromised mice | 8 wk | Dental pulp tissue containing sensory nerves and blood vessels regenerated after HDPSCs transplantation | ||
Human | α-MEM + 10% (FBS + NEAA + P/S) | - | - | 3 × 105 cells | Rats injected into the dorsal root ganglion | 2 mo | HDPSCs exhibited the morphology of neurons and expressed TRPV1 and TRPM8 | ||
Pig | PBS + P/S | Collection of hDPSCs aggregates | - | - | Permanent incisors of young female minipigs | 3 mo | Pig DPSCs resulted in the 3D regeneration of dental pulp with neural function | ||
2015 | Pig | Culture medium + 10% (FBS + L-AA -2-P + P/S) | - | Fibrin membrane | - | Porcine intercostal nerve transection model | 6 mo | DPSCs alleviated nerve injury and express NSE; neuroelectrophysiological evaluation showed that neurological function was restored | [88] |
2020 | Rat | α-MEM + 20% FBS | - | - | 1 × 106 cells/rat | Diabetic rats | 4 wk | Multiple factors secreted by DPSCs increased the nerve conduction velocity and blood flow to nerves | [118] |
2019 | Rat | α-MEM + glucose + 20% FBS | Collection of DPSCs-CM | - | 1 mL/rat | Diabetic rats | 4 wk | DPSCs-CM ameliorated peripheral neuropathy by exerting neuroprotective, angiogenic, and anti-inflammatory effects | [132] |
2017 | Rat | α-MEM + 20% FBS | - | - | 1 × 106 cells | Streptozotocin-induced diabetes rat model | 4 wk | Sensory disturbance was alleviated, the thickness and area of the myelin sheath increased, the transplanted DPSCs secreted multiple factors such as angiogenic factors, neurotrophic factors, and immunosuppressive factors | [84] |
2015 | Rat | α-MEM + glucose + 20% FBS | - | - | 1 × 106 cells | Diabetic rats | 4 wk | DPSCs transplantation relieved diabetic polyneuropathy by inhibiting inflammation, exerting immunomodulatory effects, and secreting neurotrophic factors | [86] |
2015 | Rat | α-MEM + 20% FBS | - | - | 1 × 106 cells/limb | Diabetic rats | 8 wk | DPSCs increased the nerve conduction velocity and blood flow to nerves and promoted an increase in the number of nerve fibers in diabetic rats | [83] |
2013 | Rat | DMEM + 10% (FBS + P/S) | - | - | 1.5 × 105 cells | Crush injury of the optic nerve in rats | 3 wk | Transplantation of DPSCs significantly increased the survival rate of retinal ganglion cells in rats and promote axonal regeneration | [58] |
2007 | Rat | - | Embedded in 10 mL type I collagen gel | 10-mm silicone tube | 1 × 105 cells | 7 mm defect of the facial nerve in rats | 2 wk | Regeneration of axons, blood vessels, and Schwann cells; Tuj1-positive axons and S100-positive Schwann-like supportive cells were found in regenerated nerves | [91] |
2018 | Rabbit | DMEM + 10% FBS | Construction of an acellular nerve graft for nerve regeneration | Xenogenic acellular nerve matrix | 6 × 105 cells per graft | 10 mm defect of the sciatic nerve in rabbits | 3 mo | Regeneration of nerve space showed that acellular nerve grafts containing DPSCs treated with myroilysin had a strong neural induction effect | [148] |
Publication year | Cell source | Induction protocol | Material(s) applied | Dose/concentration | Neurocyte type | Culture duration | Results | Ref. |
2022 | Human | DMEM + 20% (FBS + P/S + AA + bFGF) | Dental pulp cell sheets | 3200 cells/cm2 | SH-SY5Y neuroblastoma cells | 3 d | Dental pulp cell sheets provided neurotrophic support by expressing NTF; the amount of neurotrophic factors produced by dental pulp cell sheets was sufficient to induce nerve regeneration in vitro and promote nerve repair in vivo; dental pulp cell sheets improved axon guidance and reduced axon branching | [113] |
2020 | Rat | α-MEM + 10% (FBS + P/S + NEAA) | DPSCs-CM | - | TGNCs from rats | 3 wk | DPSCs-CM was found to contain significant levels of nerve growth factor, brain-derived neurotrophic factor, neurotrophic factor-3, and glial cell line-derived neurotrophic factor; DPSCs-CM increased the survival rate of primary trigeminal ganglion neurons and promoted the growth of neurites | [130] |
2020 | Rat | α-MEM + 10% (FBS + P/S + NEAA) | DPSCs-CM | 50% DPSCs-CM | PC12 cells | 8 d | DPSCs-CM was found to contain neurotrophic factors, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor, which increased the viability and differentiation of PC12 cells and played an important role in axonal growth and survival, proving that DPSCs-CM treatment is a potential cell-free therapy for peripheral nerve repair and has a stronger effect on PC12 cells than DPSCs | [115] |
- Citation: Xing WB, Wu ST, Wang XX, Li FY, Wang RX, He JH, Fu J, He Y. Potential of dental pulp stem cells and their products in promoting peripheral nerve regeneration and their future applications. World J Stem Cells 2023; 15(10): 960-978
- URL: https://www.wjgnet.com/1948-0210/full/v15/i10/960.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v15.i10.960